| Page properties | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Excerpt Include | ||||||
|---|---|---|---|---|---|---|
|
| Scroll Ignore | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
| Scroll Only | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
|
| Scroll Ignore | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
|
| Scroll Ignore | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Page At A Glance
|
Introduction
Te Whatu Ora - Health New Zealand works with health agencies and their industry partners to develop SNOMED CT® reference sets, maps, language reference sets and other content for digital health solutions in Aotearoa New Zealand.
The SNOMED CT New Zealand Extension packages these components for release every April and October, to be used with the latest designated SNOMED CT International Edition release.
The same content can be viewed online using the SNOMED CT browser and accessed via our standard SNOMED CT terminology service.
We welcome your feedback and participation. For more information about SNOMED CT implementation in New Zealand, see our website or join our standards channel at forum.hinz.org.nz.
Background
This document provides a summarized description of the content changes included in the October 2022 production release of the SNOMED CT NZ Extension package.
It will also include technical notes detailing any known issues which have been identified. These are content or technical issues where the root cause is understood, and the fix has been discussed and agreed, but has yet to be implemented.
This SNOMED CT NZ Extension package is dependent upon, and should therefore be consumed in conjunction with the SNOMED CT July 2022 International Edition release.
Content development activity
Summary
Content from the SNOMED CT July 2022 International Edition release has been incremented, using additional components for use in New Zealand.
The October 2022 release includes updates to the previously released content in the SNOMED CT NZ Extension release and introduces some new content.
New and updated content
Concept statistics
The SNOMED NZ National Release Centre promoted 25 new concepts into the SNOMED CT July 2022 International Edition release.
Table 1. New concepts in the SNOMED International July 2022 release by hierarchy
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 60%,20% sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
| Total number of concepts | 25 |
|---|---|
| Body structure (body structure) | 2 |
| Procedure (procedure) | 9 |
| Qualifier value (qualifier value) | 10 |
| Situation with explicit context (situation) | 4 |
Refer to Appendix 1, Table 1.1 to view the 25 new concepts.
There are 213 new concepts in this release.
Table 2. New concepts in the SNOMED CT NZ Extension October 2022 release by hierarchy
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 60%,20% sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
Total number of concepts | 213 |
|---|---|
Clinical finding (finding) | 18 |
| Disease (disorder) | 11 |
| SNOMED CT Model Component (metadata) | 3 |
Observable entity (observable entity) | 3 |
| Procedure (procedure) | 17 |
Qualifier value (qualifier value) | 71 |
| Regimes and therapies (regime/therapy) | 51 |
Situation with explicit context (situation) | 34 |
| Social context (social concept) | 5 |
Refer to Appendix 1, Table 2.1 to view the 213 new concepts.
Description statistics
The SNOMED NZ NRC promoted 0 new descriptions to the SNOMED CT International Edition July 2022 release.
Table 3. New descriptions in the SNOMED International July 2022 release
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 20%,40%,40%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
SNOMED CT Concept ID (SCTID) | SNOMED CT Fully Specified Name (FSN) | New description |
|---|---|---|
- | - | - |
There are 7 new descriptions in this release.
Table 4 New descriptions in the SNOMED CT NZ Extension October 2022 release
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 20%,40%,40%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
| SNOMED CT Concept ID (SCTID) | SNOMED CT Fully Specified Name (FSN) | New description |
|---|---|---|
| 91489000 | Acute vascular insufficiency of intestine (disorder) | Acute mesenteric ischaemia |
192759008 | Cerebral venous sinus thrombosis (disorder) | CVST-Cerebral venouse sinus thrombosis |
43185009 | Mild dysplasia (morphologic abnormality) | Low grade dysplasia |
55237006 | Severe dysplasia (morphologic abnormality) | High grade dysplasia |
385658003 | Done (qualifier value) | Completed |
| 700232004 | General medical service (qualifier value) | General medicine service |
| 310078000 | Medical microbiology service (qualifier value) | Microbiology service |
Reference sets
There are 59 reference sets in the October 2022 release.
For more information about New Zealand reference sets, please visit our website.
The New Zealand reference set list is available in Appendix 1, table 3.1.
Language reference sets
Language reference sets are created to define preferred terms and synonyms associated with each concept. There are three language reference sets in the October 2022 release.
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 60%,20%,20%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
Language Reference Set Name | SNOMED CT Concept ID (SCTID) | Members |
|---|---|---|
Maori [International Organization for Standardization 639-1 code mi] language reference set (foundation metadata concept) | 291000210106 | 157 |
New Zealand English language reference set (foundation metadata concept) | 271000210107 | 1155061 |
New Zealand English patient friendly terms language reference set (foundation metadata concept) | 281000210109 | 157 |
Maps
Five maps between SNOMED CT and other code systems are contained in the October 2022 release.
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 60%,20%,20%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
Map Name | SNOMED CT Concept ID (SCTID) | Members |
|---|---|---|
ACC translation table map (foundation metadata concept) | 401000210101 | 12795 |
MSD translation table map (foundation metadata concept) | 411000210104 | 58134 |
NZMT medicinal product to SNOMED CT map (foundation metadata concept) | 311000210107 | 2125 |
READ v2 to SNOMED CT map (foundation metadata concept) | 31000210106 | 88273 |
SNOMED CT to READ v2 map (foundation metadata concept) | 41000210103 | 66966 |
Technical notes
Known Issues
Known Issues are content or technical issues where the root cause is understood, and the resolution has been discussed and agreed but has yet to be implemented. This can be due to a number of reasons, from lack of capacity within the current editing cycle, to the risk of impact to the stability of SNOMED CT if the fix were to be deployed at that stage in the Product lifecycle.
The following known issues were identified, and agreed to be resolved in the next editing cycle:
| Scroll Table Layout | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Jira | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Notice of changes to the International Edition Release Schedule
As you may already know SNOMED International are transitioning have transitioned to a monthly delivery schedule for the International Edition of SNOMED CT. The move towards more frequent releases of SNOMED CT will realize several realizes several benefits, including:
- The potential to be able to get content changes into the terminology in a shorter time frame.
- The fostering of better interoperability, as a result of entities being able to consume release content that is more aligned with other organizations.
- The prevention of circular dependencies that occur in longer projects, due to the move towards smaller, more manageable authoring projects.
- More automated validation services, as a result of the inherent removal of the Alpha/Beta stages in the Release cycle.
Whilst most users will continue unaffected (as they can simply continue to download the releases every 6 months as always), this transition will necessarily involve a few changes to process/packages:
- Delta files have been removed from both International and Managed Service release packages, including the New Zealand Extension. A Delta Generation service will be provided for those who need it. The Delta Generation Tool allows users to create their own Delta between two fixed release dates - you can find it here:
- The ICD-O/ICD-10 Maps will continue to be published in each Monthly International Edition release package (in line with that month's content) for the foreseeable future, unless we experience issues with the new process in Production, and they need to be removed at a later date.
The first monthly Release of the SNOMED CT International Edition was published on the 28th February 2022 with the Delta files having been removed, and therefore they will be removed from the New Zealand Extension from the October 2022 Release onwards.
Please note - While the SNOMED CT International Edition is moving to monthly releases, the New Zealand Extension of SNOMED CT will remain on the current bi-annual release schedule of April and October for 2022.
Appendix 1
Table 1.1. New concepts in SNOMED CT International Edition July 2022 release
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 20%,60%,20%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
SNOMED CT Concept ID (SCTID) | SNOMED CT Fully Specified Name (FSN) | Semantic tag |
|---|---|---|
| 1217007000 | Structure of left vastus lateralis muscle (body structure) | Body structure |
| 1217006009 | Structure of right vastus lateralis muscle (body structure) | Body structure |
| 1196929001 | Computed tomography dual phase study of abdomen with contrast (procedure) | Procedure |
| 1196930006 | Computed tomography dual phase study of kidney (procedure) | Procedure |
| 1196925007 | Computed tomography of head, neck and thorax with contrast (procedure) | Procedure |
| 1196926008 | Computed tomography triple phase study of pancreas (procedure) | Procedure |
| 1196932003 | Computed tomography venography of vein of upper limb with contrast (procedure) | Procedure |
| 1204278004 | Cryoablation of lesion using fluoroscopic guidance (procedure) | Procedure |
| 1204075006 | Discography of cervical spine using fluoroscopic guidance (procedure) | Procedure |
| 1204074005 | Discography of thoracic spine using fluoroscopic guidance (procedure) | Procedure |
| 1197441007 | Ultrasonography of kidney with contrast (procedure) | Procedure |
| 1230045006 | Cardiac diagnostic service (qualifier value) | Qualifier value |
| 1230044005 | Cardiac specialist nursing service (qualifier value) | Qualifier value |
| 1230046007 | Cervical cancer screening service (qualifier value) | Qualifier value |
| 1231391000 | Colonoscopy service (qualifier value) | Qualifier value |
| 1234796008 | Community nursing service (qualifier value) | Qualifier value |
| 1231390004 | Hand therapy service (qualifier value) | Qualifier value |
| 1231392007 | Pediatric orthopedic service (qualifier value) | Qualifier value |
| 1231394008 | Pediatric urology service (qualifier value) | Qualifier value |
| 1231786003 | Refugee healthcare service (qualifier value) | Qualifier value |
| 1231393002 | Spirometry service (qualifier value) | Qualifier value |
| 1234920002 | Diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccination given (situation) | Situation |
| 1234918000 | Haemophilus influenza type B vaccination given (situation) | Situation |
| 1234922005 | Varicella-zoster vaccination for chicken pox given (situation) | Situation |
| 1234919008 | Varicella-zoster vaccination given (situation) | Situation |
Table 2.1. New concepts in the SNOMED CT NZ Extension October 2022 release
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 20%,60%,20%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
SNOMED CT Concept ID (SCTID) | SNOMED CT Fully Specified Name (FSN) | Semantic tag |
|---|---|---|
| 181821000210104 | Metastasis from biliary tract (disorder) | Disorder |
| 192061000210109 | Metastasis from gastrointestinal stromal tumor (disorder) | Disorder |
| 191621000210101 | Metastasis from malignant neoplasm of gallbladder and biliary tract (disorder) | Disorder |
| 191681000210100 | Metastasis from malignant neoplasm of nasopharynx (disorder) | Disorder |
| 191671000210102 | Metastasis from malignant tumor of salivary gland (disorder) | Disorder |
| 181811000210109 | Metastasis from merkel cell carcinoma (disorder) | Disorder |
| 181781000210106 | Metastasis from mesothelioma (disorder) | Disorder |
| 181771000210109 | Metastasis from non-small cell lung cancer (disorder) | Disorder |
| 181791000210108 | Metastasis from small cell carcinoma (disorder) | Disorder |
| 181801000210107 | Primary malignant melanoma of skin (disorder) | Disorder |
| 181841000210105 | Primary of malignant neoplasm of gallbladder and biliary tract (disorder) | Disorder |
| 161901000210103 | Abnormal pattern finding (finding) | Finding |
| 161721000210108 | Eligible for influenza immunization programme due to medical condition (finding) | Finding |
| 161751000210104 | Eligible for influenza immunization programme due to pregnancy (finding) | Finding |
| 161761000210101 | Eligible for influenza immunization programme for Māori and/or Pacific person aged 55 to 64 years of age (finding) | Finding |
| 161771000210107 | Eligible for influenza immunization programme for people 65 years of age and older (finding) | Finding |
| 161731000210105 | Eligible for inluenza immunization programme for child four years of age or under due to history of hospitalization with respiratory condition (finding) | Finding |
| 161681000210102 | Eligible for publicly funded health service (finding) | Finding |
| 201591000210104 | Immunity confirmed by documented serology (finding) | Finding |
| 161871000210103 | Intact nuclear expression (finding) | Finding |
| 161881000210101 | Loss of nuclear expression (finding) | Finding |
| 161701000210100 | Meets eligibility criteria for publicly funded health service (finding) | Finding |
| 161711000210103 | Meets eligibility criteria for vaccination programme (finding) | Finding |
| 161691000210100 | Not eligible for publicly funded health service (finding) | Finding |
| 161821000210102 | Surgical margin involved by adenoma (finding) | Finding |
| 161841000210108 | Surgical margin involved by adenoma with high grade dysplasia (finding) | Finding |
| 161831000210100 | Surgical margin involved by adenoma with low grade dysplasia (finding) | Finding |
| 161851000210106 | Surgical margin involved by sessile serrated lesion (finding) | Finding |
| 161861000210109 | Surgical margin not involved by adenoma with dysplasia (finding) | Finding |
| 192081000210101 | New Zealand priority score reference set (foundation metadata concept) | Foundation metadata concept |
| 192071000210103 | New Zealand referral status reference set (foundation metadata concept) | Foundation metadata concept |
| 192091000210104 | New Zealand suspicion of cancer reference set (foundation metadata concept) | Foundation metadata concept |
| 161671000210104 | Eligibility for influenza immunization programme (observable entity) | Observable entity |
| 161661000210105 | Eligibility for publicly funded health service (observable entity) | Observable entity |
| 161741000210102 | Eligibility for vaccination programme (observable entity) | Observable entity |
| 191781000210107 | Administration of prophylactic anticonvulsant (procedure) | Procedure |
| 181651000210109 | Prevention of diphtheria, tetanus and pertussis (procedure) | Procedure |
| 181641000210106 | Prevention of diphtheria, tetanus, pertussis and polio (procedure) | Procedure |
| 181631000210103 | Prevention of diphtheria, tetanus, pertussis, polio, hepatitis B and Haemophilus influenzae type b (procedure) | Procedure |
| 181621000210100 | Prevention of Haemophilus influenzae type b infection (procedure) | Procedure |
| 181611000210105 | Prevention of herpes zoster (procedure) | Procedure |
| 181601000210108 | Prevention of human papillomavirus infection (procedure) | Procedure |
| 181561000210108 | Prevention of influenza (procedure) | Procedure |
| 171841000210100 | Prevention of measles, mumps and rubella (procedure) | Procedure |
| 181581000210100 | Prevention of pneumococcal disease (procedure) | Procedure |
| 181571000210102 | Prevention of Rotavirus (procedure) | Procedure |
| 181551000210105 | Prevention of severe acute respiratory syndrome coronavirus 2 (procedure) | Procedure |
| 181591000210103 | Prevention of varicella (procedure) | Procedure |
| 171661000210103 | Provision for longer appointment time (procedure) | Procedure |
| 171671000210109 | Provision for New Zealand sign language interpreter service (procedure) | Procedure |
| 171651000210101 | Provision for wheelchair access (procedure) | Procedure |
| 171681000210106 | Provision of spacious environment for mobility (procedure) | Procedure |
| 191631000210104 | Abuse and violence service (qualifier value) | Qualifier value |
| 171761000210107 | Abuse prevention service | Qualifier value |
| 171741000210106 | Acupuncture service | Qualifier value |
| 161961000210104 | Aged residential care hospital level respite service (qualifier value) | Qualifier value |
| 161931000210108 | Aged residential care hospital level service (qualifier value) | Qualifier value |
| 161971000210105 | Aged residential care respite service (qualifier value) | Qualifier value |
| 161911000210101 | Aged residential care service (qualifier value) | Qualifier value |
| 171621000210105 | Anger management service (qualifier value) | Qualifier value |
| 141541000210102 | Asian support service (qualifier value) | Qualifier value |
| 181691000210102 | Auditory processing disorder service (qualifier value) | Qualifier value |
| 171701000210108 | Cancer support service (qualifier value) | Qualifier value |
| 192011000210107 | Chinese medicine service (qualifier value) | Qualifier value |
| 192111000210108 | Community care coordination service (qualifier value) | Qualifier value |
| 171811000210101 | Community patient support service (qualifier value) | Qualifier value |
| 181831000210102 | Disability supported accommodation service (qualifier value) | Qualifier value |
| 171691000210108 | Driving and vehicle adaptation assesment service (qualifier value) | Qualifier value |
| 171591000210107 | Ear nurse specialist service (qualifier value) | Qualifier value |
| 141581000210109 | Early pregnancy assessment service (qualifier value) | Qualifier value |
| 151551000210102 | Eating disorder service (qualifier value) | Qualifier value |
| 171611000210100 | Elder abuse response service (qualifier value) | Qualifier value |
| 191601000210109 | Expired (qualifier value) | Qualifier value |
| 192101000210106 | Family violence intervention service (qualifier value) | Qualifier value |
| 141521000210108 | Family whānau support services (qualifier value) | Qualifier value |
| 161561000210106 | High to moderate emetic risk (qualifier value) | Qualifier value |
| 141531000210105 | Home care support service (qualifier value) | Qualifier value |
| 192051000210106 | Hospital administrative service (qualifier value) | Qualifier value |
| 24081000087105 | Human immunodeficiency virus nurse practitioner service (qualifier value) | Qualifier value |
| 181701000210102 | Immigration medical service (qualifier value) | Qualifier value |
| 171791000210102 | Immunization service (qualifier value) | Qualifier value |
| 181751000210101 | Infusion service (qualifier value) | Qualifier value |
| 141561000210101 | Intellectual disability residential care respite service (qualifier value) | Qualifier value |
| 171641000210104 | Kaupapa Māori service (qualifier value) | Qualifier value |
| 181761000210103 | Lesbian, Gay, Bisexual,Transgender, Queer, Intersexed and Asexual support service (qualifier value) | Qualifier value |
| 161551000210108 | Low to minimal emetic risk (qualifier value) | Qualifier value |
| 171771000210101 | Mobility equipment support service (qualifier value) | Qualifier value |
| 191571000210103 | Not determined - pending test (qualifier value) | Qualifier value |
| 191581000210101 | Not prioritised (qualifier value) | Qualifier value |
| 192021000210102 | Occupational medicine service (qualifier value) | Qualifier value |
| 171751000210109 | Osteopathy service | Qualifier value |
| 192041000210108 | Outreach service (qualifier value) | Qualifier value |
| 91581000210106 | Pacific Island people service (qualifier value) | Qualifier value |
| 171821000210106 | Parenting support service | Qualifier value |
| 171711000210105 | Patient transport service (qualifier value) | Qualifier value |
| 151561000210104 | Pediatric vision and hearing service (qualifier value) | Qualifier value |
| 171781000210104 | Pediatric vision service | Qualifier value |
| 191611000210106 | Pending (qualifier value) | Qualifier value |
| 141571000210107 | Physical disability residential care respite service (qualifier value) | Qualifier value |
| 171801000210103 | Physical exercise service (qualifier value) | Qualifier value |
| 171581000210105 | Pre-admission assessment service (qualifier value) | Qualifier value |
| 191691000210103 | Priority not stated (qualifier value) | Qualifier value |
| 161941000210100 | Psychogeriatric residential care hospital level respite service (qualifier value) | Qualifier value |
| 161951000210102 | Psychogeriatric residential care respite service (qualifier value) | Qualifier value |
| 161921000210106 | Psychogeriatric residential care service (qualifier value) | Qualifier value |
| 171631000210107 | Refuge service (qualifier value) | Qualifier value |
| 191591000210104 | Rejected (qualifier value) | Qualifier value |
| 192121000210103 | Rural hospital service (qualifier value) | Qualifier value |
| 181731000210107 | School health service (qualifier value) | Qualifier value |
| 181711000210100 | Screening service (qualifier value) | Qualifier value |
| 191561000210109 | Semi urgent (qualifier value) | Qualifier value |
| 151531000210108 | Sexual abuse medicine service (qualifier value) | Qualifier value |
| 151521000210106 | Sexual harm service (qualifier value) | Qualifier value |
| 181721000210105 | Specimen collection service (qualifier value) | Qualifier value |
| 181741000210104 | Tertiary education student health service (qualifier value) | Qualifier value |
| 161891000210104 | Test failed (qualifier value) | Qualifier value |
| 191661000210108 | Transferred (qualifier value) | Qualifier value |
| 171831000210108 | Transfusion service (qualifier value) | Qualifier value |
| 171721000210100 | Transport service (qualifier value) | Qualifier value |
| 141591000210106 | Urgent care medical service (qualifier value) | Qualifier value |
| 191641000210107 | Violence prevention service (qualifier value) | Qualifier value |
| 192031000210100 | Well child service (qualifier value) | Qualifier value |
| 141511000210103 | Youth support service (qualifier value) | Qualifier value |
| 59301000210102 | Breast metastatic - CMF classical IV cyclophosphamide, methotrexate and fluorouracil chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59151000210103 | Breast metastatic - docetaxel and trastuzumab triweekly chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59131000210109 | Breast metastatic AC doxorubicin and cyclophosphamide chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59191000210105 | Breast metastatic capecitabine 1000 and trastuzumab triweekly chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59181000210108 | Breast metastatic docetaxel triweekly chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59171000210106 | Breast metastatic docetaxel, pertuzumab and trastuzumab chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59161000210100 | Breast non-metastatic AC doxorubicin and cyclophosphamide triweekly followed by paclitaxel weekly chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59121000210107 | Breast non-metastatic AC TH doxorubicin and cyclophosphamide triweekly followed by docetaxel and trastuzumab triweekly chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59311000210100 | Breast non-metastatic CMF classical IV cyclophosphamide, methotrexae and fluorouracil chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59141000210101 | Breast non-metastatic FEC-D75 fluorouracil, epirubicin and cyclophosphamide followed by docetaxel chemotherapy regimen (regime/therapy) | Regime/therapy |
| 211601000210107 | Childhood immunization program (regime/therapy) | Regime/therapy |
| 191831000210103 | Cytomegalovirus infection monitoring (regime/therapy) | Regime/therapy |
| 59381000210106 | Head and neck nasopharyngeal metastatic gemcitabine and carboplatin chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59361000210103 | Head and neck nasopharyngeal metastatic gemcitabine and cisplatin chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59441000210109 | Head and neck nasopharyngeal non-metastatic cisplatin triweekly chemoradiation followed by cisplatin and fluorouracil chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59331000210107 | Head and neck nasopharyngeal non-metastatic cisplatin weekly chemoradiation (regime/therapy) | Regime/therapy |
| 59431000210101 | Head and neck salivary gland metastatic CAP cyclophosphamide, doxorubicin and cisplatin chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59461000210105 | Head and neck salivary gland metastatic cisplatin and vinorelbine intavenous chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59201000210107 | Head and neck squamous cell metastatic - pembrolizumab triweekly flat dosing chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59351000210101 | Head and neck squamous cell metastatic carboplatin and paclitaxel chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59371000210109 | Head and neck squamous cell metastatic carboplatin, fluorouracil and pembrolizumab chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59341000210104 | Head and neck squamous cell metastatic cisplatin and fluorouracil chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59421000210103 | Head and neck squamous cell metastatic cisplatin, fluorouracil and pembrolizumab chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59411000210108 | Head and neck squamous cell metastatic nivolumab biweekly flat dosing chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59251000210108 | Head and neck squamous cell metastatic nivolumab every four weeks flat dosing chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59221000210104 | Head and neck squamous cell metastatic nivolumab weight-based dosing chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59401000210106 | Head and neck squamous cell metastatic paclitaxel weekly chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59211000210109 | Head and neck squamous cell metastatic pembrolizumab every six weeks flat dosing chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59391000210108 | Head and neck squamous cell metastatic pembrolizumab triweekly weight based dosing chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59231000210102 | Head and neck squamous cell non-metastatic carboplatin and fluorouracil chemoradiation (regime/therapy) | Regime/therapy |
| 59451000210107 | Head and neck squamous cell non-metastatic cisplatin triweekly chemoradiation (regime/therapy) | Regime/therapy |
| 59321000210105 | Head and neck squamous cell non-metastatic cisplatin weekly chemoradition (regime/therapy) | Regime/therapy |
| 59241000210105 | Head and neck squamous cell non-metastatic cisplatin weekly post-operative chemoradiation (regime/therapy) | Regime/therapy |
| 201601000210109 | Hepatitis type B immunization program (regime/therapy) | Regime/therapy |
| 211631000210102 | Human papillomavirus immunization program (regime/therapy) | Regime/therapy |
| 211591000210102 | Immunization program (regime/therapy) | Regime/therapy |
| 211641000210105 | Meningococcal B immunization program (regime/therapy) | Regime/therapy |
| 211611000210109 | New Zealand national immunization program (regime/therapy) | Regime/therapy |
| 201611000210106 | Pneumococcal immunization program (regime/therapy) | Regime/therapy |
| 59281000210103 | Respiratory non small cell lung cancer metastatic cisplatin and gemcitabine chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59291000210101 | Respiratory non small cell lung cancer non-metastatic cisplatin and gemcitabine chemoradiation (regime/therapy) | Regime/therapy |
| 59271000210100 | Respiratory non small cell lung cancer non-metastatic cisplatin and vinblastine chemoradiation (regime/therapy) | Regime/therapy |
| 211651000210108 | Severe acute respiratory syndrome coronavirus 2 immunization program (regime/therapy) | Regime/therapy |
| 211621000210104 | Tuberculosis immunization program (regime/therapy) | Regime/therapy |
| 59111000210102 | Upper gastrointestinal gastric and oesophageal metastatic docetaxel chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59071000210107 | Upper gastrointestinal pancreas metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy) | Regime/therapy |
| 57731000210103 | Upper gastrointestinal pancreas non-metastatic modified oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59081000210109 | Upper gastrointestinal pancreas non-metastatic modififed oxaliplatin, irinotecan, folinic acid and fluorouracil high dose folinic acid chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59091000210106 | Upper gastrointestinal pancreas non-metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil high dose folinic acid chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59101000210104 | Upper gastrointestinal pancreas non-metastatic oxaliplatin, irinotecan, folinic acid and fluorouracil low dose folinic acid chemotherapy regimen (regime/therapy) | Regime/therapy |
| 59261000210106 | Urogenital prostate metastatic zoledronic acid every six weeks chemotherapy regimen (regime/therapy) | Regime/therapy |
| 201581000210101 | Alternate vaccination given (situation) | Situation |
| 191811000210105 | Anticonvulsant prophylaxis to be done (situation) | Situation |
| 191841000210106 | Cytomegalovirus infection monitoring recommended (situation) | Situation |
| 191871000210101 | Folinic acid rescue therapy to be done (situation) | Situation |
| 191821000210100 | Graft-versus-host disease prophylaxis to be done (situation) | Situation |
| 191701000210103 | Hepatitis B virus prophylaxis recommended (situation) | Situation |
| 191741000210100 | Hepatitis B virus prophylaxis to be done (situation) | Situation |
| 191881000210104 | Hepatitis B virus prophylaxis under consideration (situation) | Situation |
| 191751000210102 | Herpesvirus infection prophylaxis recommended (situation) | Situation |
| 191711000210101 | Herpesvirus infection prophylaxis to be done (situation) | Situation |
| 191891000210102 | Herpesvirus infection prophylaxis under consideration (situation) | Situation |
| 201571000210103 | History of vaccination given in another country (situation) | Situation |
| 161811000210107 | Privately funded vaccination given (situation) | Situation |
| 191961000210102 | Proton pump inhibitor therapy recommended (situation) | Situation |
| 191971000210108 | Proton pump inhibitor therapy to be done (situation) | Situation |
| 191951000210100 | Proton pump inhibitor therapy under consideration (situation) | Situation |
| 161641000210109 | Publicly funded vaccination given due to medical condition included in criteria list (situation) | Situation |
| 161631000210101 | Publicly funded vaccination given due to pregnancy (situation) | Situation |
| 161651000210107 | Publicly funded vaccination given for 65 years of age or older (situation) | Situation |
| 161801000210105 | Publicly funded vaccination given for child four years of age or under due to history of hospitalization with respiratory condition (situation) | Situation |
| 161791000210106 | Publicly funded vaccination given to Māori and Pacific people aged 55 to 64 years of age (situation) | Situation |
| 181661000210107 | Suspected malignancy - high (situation) | Situation |
| 181671000210101 | Suspected malignancy - low (situation) | Situation |
| 181681000210104 | Suspected malignancy - not stated (situation) | Situation |
| 191911000210104 | Thrombosis prophylaxis recommended (situation) | Situation |
| 191931000210106 | Thrombosis prophylaxis to be done (situation) | Situation |
| 191921000210109 | Thrombosis prophylaxis under consideration (situation) | Situation |
| 191761000210104 | Tumor lysis syndrome prophylaxis (procedure) | Situation |
| 191901000210101 | Tumor lysis syndrome prophylaxis recommended (situation) | Situation |
| 191801000210108 | Tumor lysis syndrome prophylaxis to be done (situation) | Situation |
| 191791000210109 | Tumor lysis syndrome prophylaxis under consideration (situation) | Situation |
| 191851000210109 | Veno-occlusive disease of the liver prophylaxis (procedure) | Situation |
| 191861000210107 | Veno-occlusive disease of the liver prophylaxis recommended (situation) | Situation |
| 191941000210103 | Veno-occlusive disease of the liver prophylaxis under consideration (situation) | Situation |
| 211701000210101 | Cord blood stem cell donor (person) | Person |
| 211661000210106 | Matched related stem cell donor (person) | Person |
| 211671000210100 | Matched unrelated stem cell donor (person) | Person |
| 211681000210103 | Mismatched related stem cell donor (person) | Person |
| 211691000210101 | Mismatched unrelated stem cell donor (person) | Person |
Table 3.1 Reference sets in the SNOMED CT NZ Extension October 2022 release
Scroll Table Layout orientation default sortDirection ASC repeatTableHeaders default style Resolved Issues Table widths 20%,60%,20%, sortByColumn 1 tableStyling confluence sortEnabled false cellHighlighting true
SNOMED CT Concept ID (SCTID) | SNOMED CT Fully Specified Name (FSN) | Members |
|---|---|---|
351000210106 | New Zealand adverse reaction manifestation reference set (foundation metadata concept) | 1886 |
| 72671000210109 | New Zealand alcohol consumption reference set (foundation metadata concept) | 3 |
421000210109 | New Zealand ambulance clinical impression reference set (foundation metadata concept) | 176 |
| 61241000210100 | New Zealand biological substance common allergen reference set (foundation metadata concept) | 207 |
91000210107 | New Zealand cardiology reference set (foundation metadata concept) | 63 |
| 61251000210102 | New Zealand chemical substance common allergen reference set (foundation metadata concept) | 623 |
191000210102 | New Zealand child developmental services reference set (foundation metadata concept) | 137 |
241000210102 | New Zealand child health assessment reference set (foundation metadata concept) | 186 |
471000210108 | New Zealand clinical specialty reference set (foundation metadata concept) | 157 |
| 61271000210105 | New Zealand common pharmaceutical dose form reference set (foundation metadata concept) | 12 |
| 61281000210107 | New Zealand common pharmaceutical dose frequency reference set (foundation metadata concept) | 12 |
| 61291000210109 | New Zealand common pharmaceutical dose unit reference set (foundation metadata concept) | 11 |
| 61231000210108 | New Zealand COVID-19 adverse event from immunization reference set (foundation metadata concept) | 58 |
261000210101 | New Zealand disability reference set (foundation metadata concept) | 96 |
| 61261000210104 | New Zealand edible substance common allergen reference set (foundation metadata concept) | 419 |
61000210102 | New Zealand emergency care diagnosis reference set (foundation metadata concept) | 1467 |
71000210108 | New Zealand emergency care presenting complaint reference set (foundation metadata concept) | 158 |
321000210102 | New Zealand emergency care procedure reference set (foundation metadata concept) | 74 |
141000210106 | New Zealand endocrinology reference set (foundation metadata concept) | 263 |
181000210104 | New Zealand general paediatric reference set (foundation metadata concept) | 441 |
131000210103 | New Zealand general surgery reference set (foundation metadata concept) | 97 |
101000210108 | New Zealand gynaecology reference set (foundation metadata concept) | 143 |
451000210100 | New Zealand health occupation reference set (foundation metadata concept) | 87 |
461000210102 | New Zealand health service type reference set (foundation metadata concept) | 228 |
501000210102 | New Zealand laboratory order reference set (foundation metadata concept) | 956 |
| 72621000210105 | New Zealand maternity Apgar score reference set (foundation metadata concept) | 33 |
| 72631000210107 | New Zealand maternity complementary therapies reference set (foundation metadata concept) | 17 |
72601000210102 | New Zealand maternity complications reference set (foundation metadata concept) | 32 |
72611000210100 | New Zealand maternity disorders reference set (foundation metadata concept) | 44 |
72661000210103 | New Zealand maternity family history reference set (foundation metadata concept) | 12 |
72591000210107 | New Zealand maternity findings reference set (foundation metadata concept) | 156 |
72581000210105 | New Zealand maternity mode of delivery reference set (foundation metadata concept) | 4 |
72571000210108 | New Zealand maternity outcomes reference set (foundation metadata concept) | 8 |
72541000210103 | New Zealand maternity previous complications reference set (foundation metadata concept) | 47 |
72551000210100 | New Zealand maternity previous disorders reference set (foundation metadata concept) | 63 |
72531000210106 | New Zealand maternity previous findings reference set (foundation metadata concept) | 49 |
72521000210109 | New Zealand maternity previous mode of delivery reference set (foundation metadata concept) | 4 |
| 72511000210104 | New Zealand maternity previous outcomes reference set (foundation metadata concept) | 9 |
72501000210101 | New Zealand maternity previous procedures reference set (foundation metadata concept) | 23 |
72561000210102 | New Zealand maternity procedures reference set (foundation metadata concept) | 51 |
72641000210104 | New Zealand maternity screening and tests reference set (foundation metadata concept) | 21 |
72651000210101 | New Zealand maternity substances reference set (foundation metadata concept) | 13 |
391000210104 | New Zealand microorganism reference set (foundation metadata concept) | 18710 |
| 50931000210104 | New Zealand nephrology reference set (foundation metadata) | 99 |
72691000210108 | New Zealand non-medicinal drug reference set (foundation metadata concept) | 16 |
72681000210106 | New Zealand non-medicinal drug use reference set (foundation metadata concept) | 6 |
251000210104 | New Zealand notifiable disease reference set (foundation metadata concept) | 97 |
| 50941000210107 | New Zealand ophthalmology reference set (foundation metadata concept) | 64 |
| 121531000210107 | New Zealand radiology procedures reference set (foundation metadata concept) | 914 |
121000210100 | New Zealand rheumatology reference set (foundation metadata concept) | 126 |
| 192071000210103 | New Zealand referral status reference set (foundation metadata concept) | 7 |
| 121521000210105 | New Zealand severe acute respiratory syndrome coronavirus 2 symptoms reference set (foundation metadata concept) | 19 |
481000210105 | New Zealand site of care reference set (foundation metadata concept) | 8 |
| 72731000210103 | New Zealand smoking intervention reference set (foundation metadata concept) | 5 |
| 72741000210106 | New Zealand smoking status reference set (foundation metadata concept) | 4 |
441000210103 | New Zealand surgical complication reference set (foundation metadata concept) | 147 |
| 192091000210104 | New Zealand suspicion of cancer reference set (foundation metadata concept) | 4 |
| 192081000210101 | New Zealand priority score reference set (foundation metadata concept) | 7 |
| 72721000210100 | New Zealand vaping status reference set (foundation metadata concept) | 7 |
| Scroll Ignore | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Approvals
Download .pdf here: |
| Scroll Ignore | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||
Draft Amendment History
|